Lakefront Biotherapeutics (LKFT) Capital Leases (2014 - 2017)

Lakefront Biotherapeutics (LKFT) has reported Capital Leases for 4 consecutive years, with $12988.9 the latest figure, recorded in Q4 2017.

• Quarterly Capital Leases changed 0.0% year-over-year to $12988.9 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $12988.9 (changed 0.0% YoY) and the FY2017 annual result came in at $12988.9, changed 0.0% from the prior year.
• Capital Leases fell to $12988.9 in Q4 2017 per LKFT's latest filing, from $53398.8 in the prior quarter.
• Over the last five years, Capital Leases for LKFT reached as high as $165969.1 in Q4 2014 and fell as low as $12988.9 in Q4 2016.
• A 4-year average of $65975.3 and a median of $53398.8 in 2016 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2016 — Capital Leases plunged 85.71% — and 2017, when it changed 0.0%.
• Year by year, Capital Leases stood at $165969.1 in 2014, then plunged by 45.22% to $90922.2 in 2015, then tumbled by 85.71% to $12988.9 in 2016, then changed by 0.0% to $12988.9 in 2017.
• According to Business Quant data, Capital Leases over the past three periods registered $12988.9, $53398.8, and $72160.5 for Q4 2017, Q2 2017, and Q1 2017 respectively.